Growth research
Two material records for growth-hormone signaling research.
Mechanistic concept · exact-pair evidence unestablished
GHRH and secretagogue pathways converge on GH release. Related GRF evidence is not a study of this exact catalog material. Long-acting DAC trials cannot establish No DAC behavior, and the exact pair is not validated by these sources.
Compares two upstream inputs to growth-hormone signaling: a GHRH-class analogue and a growth-hormone secretagogue. Different receptor classes provide a research distinction, despite a shared downstream axis.
Published findings concern the stated study materials and models. They do not establish the exact catalog combination.
Individual product records, together for review.
1 vial
$65
CJC-1295 without DAC is a tetrasubstituted analogue of the 29-residue growth hormone-releasing hormone fragment GHRH(1–29), also called Mod GRF (1-29). This no-DAC form lacks the albumin-binding Drug Affinity Complex and is supplied as lyophilized powder in a sealed vial.
Lot documentation published
1 vial
$50
Ipamorelin is a synthetic pentapeptide containing non-proteinogenic and D-configuration residues. It belongs to the designed peptidomimetic and growth-hormone-secretagogue research class rather than a naturally occurring sequence family, and is supplied as lyophilized powder in a sealed vial.
Lot documentation published
One vial of each included product.
Individual value: $115Save $10
Ask about Growth
Contact us for current availability and lot documentation for the products in this selection.
Laboratory research only. Goal labels describe research themes, not promised outcomes or combined-use guidance. Each product is a separate catalog record. Not for human or veterinary use.